Torrent Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on April 28, 2026

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.1%1-day move

₹4186.10

prior close

₹4220.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1+0.3+0.6+1.0+0.1+1.8+2.5+4.1+4.0+7.9+6.9+5.5+10.9—

Up moveDown movePending

AI summary

Torrent Pharmaceuticals Limited held an NCLT-convened shareholders meeting on April 28, 2026 to vote on the proposed Scheme of Amalgamation involving J. B. Chemicals & Pharmaceuticals Limited (JB Pharma) merging into Torrent Pharma. The meeting lasted 21 minutes and was conducted via video conferencing. Shareholders approved the scheme with the requisite majority under Section 230(6) of the Companies Act, 2013, requiring both a simple majority and three-fourths in value of votes cast. This is a routine consolidation in the pharmaceutical sector combining two drug manufacturers.

Likely market impact

Shareholder approval clears a key regulatory hurdle for the merger. The amalgamation could strengthen Torrent Pharma's product portfolio and market position, which is generally positive for the company's outlook.